End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19Richard Pebody, Maria Zambon, Simon Cottrell et al.|Vaccine|2019Cited by 59
Quadrivalent human papillomavirus vaccination in girls and the risk of autoimmune disorders: the Ontario Grade 8 HPV Vaccine Cohort StudyErin Y. Liu, Linda E. Lévesque, Leah Smith et al.|Canadian Medical Association Journal|2018Cited by 39
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025Angela Rose, Héloïse Lucaccioni, Kimberly Marsh et al.|Eurosurveillance|2025Cited by 24
Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026Héloïse Lucaccioni, the European IVE group, Diogo F.P. Marques et al.|Eurosurveillance|2026Cited by 7
Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case studyEsther Kissling, on behalf of I-MOVE-COVID- and ECDC primary care study teams, Mariëtte Hooiveld et al.|American Journal of Epidemiology|2025Cited by 0